Fig. 1From: Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trialKaplan-Meier-Curves showing the cumulative event rates according to Epoetin beta therapy or Placebo. A Analysis of survival. B Analysis of survival free of recurrent myocardial infarction (MI). C Analysis of survival free of recurrent MI and stroke. D Analysis of survival free of MACE (recurrent MI, stroke and reintervention)Back to article page